Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Jennifer R Ribeiro"'
Publikováno v:
Frontiers in Oncology, Vol 4 (2014)
As ovarian tumors progress, they undergo a process of dedifferentiation, allowing adaptive changes in growth and morphology that promote metastasis and chemoresistance. Herein, we outline a hypothesis that TATA-box binding protein (TBP) associated fa
Externí odkaz:
https://doaj.org/article/10556480ee57440a9d429e83bb76ca83
Autor:
Gino K. In, Jennifer R. Ribeiro, Jun Yin, Joanne Xiu, Matias A. Bustos, Fumito Ito, Frances Chow, Gabriel Zada, Lindsay Hwang, April K. S. Salama, Soo J. Park, Justin C. Moser, Sourat Darabi, Evidio Domingo-Musibay, Maria L. Ascierto, Kim Margolin, Jose Lutzky, Geoffrey T. Gibney, Michael B. Atkins, Benjamin Izar, Dave S. B. Hoon, Ari M. VanderWalde
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-10 (2023)
Abstract Melanoma brain metastases (MBM) are clinically challenging to treat and exhibit variable responses to immune checkpoint therapies. Prior research suggests that MBM exhibit poor tumor immune responses and are enriched in oxidative phosphoryla
Externí odkaz:
https://doaj.org/article/32efd05519e741b4bbdba359b3adab39
Autor:
Nicole E. James, Jenna B. Emerson, Ashley D. Borgstadt, Lindsey Beffa, Matthew T. Oliver, Virginia Hovanesian, Anze Urh, Rakesh K. Singh, Rachael Rowswell-Turner, Paul A. DiSilvestro, Joyce Ou, Richard G. Moore, Jennifer R. Ribeiro
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-12 (2020)
Abstract Epithelial ovarian cancer (EOC) is a highly lethal gynecologic malignancy arising from the fallopian tubes that has a high rate of chemoresistant recurrence and low five-year survival rate. The ovarian cancer biomarker HE4 is known to promot
Externí odkaz:
https://doaj.org/article/1e2034decd7b4213a5c0a5824478d5c9
Autor:
Shaina F. Bruce, Sharon Wu, Jennifer R. Ribeiro, Alex Farrell, Matthew J. Oberley, Ira Winer, Britt K. Erickson, Tenley Klc, Nathaniel L. Jones, Premal H. Thaker, Matthew A. Powell
Publikováno v:
Gynecologic Oncology. 172:98-105
Autor:
Nicole E. James, Katherine Miller, Natalie LaFranzo, Erin Lips, Morgan Woodman, Joyce Ou, Jennifer R. Ribeiro
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Epithelial ovarian cancer (EOC) is the most lethal gynecologic malignancy worldwide, as patients are typically diagnosed at a late stage and eventually develop chemoresistant disease following front-line platinum-taxane based therapy. Only modest res
Externí odkaz:
https://doaj.org/article/7845a4052e6d4d61941d67d8b61f0519
Autor:
Ifeanyichukwu Ogobuiro, Yasmine Baca, Jennifer R Ribeiro, Phillip Walker, Gregory C Wilson, Prateek Gulhati, John L Marshall, Rachna T Shroff, David Spetzler, Matthew J Oberley, Daniel E Abbott, Hong Jin Kim, David A Kooby, Shishir K Maithel, Syed A Ahmad, Nipun B. Merchant, Joanne Xiu, Peter J. Hosein, Jashodeep Datta
Publikováno v:
medRxiv
PurposeUsing a real-world database with matched genomic-transcriptomic molecular data, we sought to characterize the distinct molecular correlates underlying clinical differences between young-onset pancreatic cancer (YOPC; MethodsWe analyzed matched
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08c99b4a2810d8f89c23a8f69187a400
https://europepmc.org/articles/PMC10081424/
https://europepmc.org/articles/PMC10081424/
Publikováno v:
Oncogene. 41:1389-1396
Autor:
Anze Urh, Ravina Pandita, Naohiro Yano, Sindhuja Kadambi, Negar Khazan, Nicole E. James, David C. Linehan, Rachael B. Rowswell-Turner, Rakesh K. Singh, Richard G. Moore, Kyu Kwang Kim, Jennifer R. Ribeiro, Umayal Sivagnanalingam, Virginia Hovanesian
Publikováno v:
The Journal of Immunology. 206:2478-2488
Ovarian cancer is a highly fatal malignancy characterized by early chemotherapy responsiveness but the eventual development of resistance. Immune targeting therapies are changing treatment paradigms for numerous cancer types but have had minimal succ
Autor:
Nicole E. James, Morgan Woodman, Payton De La Cruz, Katrin Eurich, Melih Arda Ozsoy, Christoph Schorl, Linda C. Hanley, Jennifer R. Ribeiro
Publikováno v:
Frontiers in immunology. 13
The high rate of ovarian cancer recurrence and chemoresistance necessitates further research into how chemotherapy affects the tumor immune microenvironment (TIME). While studies have shown that immune infiltrate increases following neoadjuvant (NACT
Autor:
Nicole E, James, Ashley D, Valenzuela, Jenna B, Emerson, Morgan, Woodman, Katherine, Miller, Virginia, Hovanesian, Joyce, Ou, Jennifer R, Ribeiro
Publikováno v:
Oncology Letters. 23
Patients with ovarian cancer exhibit low response rates to anti-programmed cell death protein-1 (PD-1) based therapies, despite ovarian tumors demonstrating measurable immune responses. Therefore, the aim of the present study was to comparatively exa